British Heart Foundation Features Breakthrough Heart Attack Prevention Technology in Online News Programme for World Heart Day
CaRi-Heart® Users share Excitement on Potential for Heart Attack Prediction and Prevention
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
29 Sep 23
CaRi-Heart® Users share Excitement on Potential for Heart Attack Prediction and Prevention
04 Sep 23
Lupin Pharma Canada Ltd., a wholly-owned subsidiary of Lupin Limited (Lupin), today announced the launch of Propranolol LA…
01 Sep 23
The ACTIMIS clinical trial evaluating glenzocimab in combination with the reference treatment in patients presenting with AIS has…
28 Aug 23
Two implants were successfully conducted as part of the FDA approved Early Feasibility Study in the United States
27 Jul 23
Reduction in blood oxygen levels, largely attributed to blocked airways, emerges as a leading factor.
02 Nov 22
The transaction, which has been unanimously approved by boards of directors of both companies, is expected to be…
22 Feb 22
The expanded FDA approval enables patients with Class II heart failure and elevated levels of natriuretic peptides to…
21 Feb 22
The Freezor and Freezor Xtra catheters are flexible, single-use devices that freeze the cardiac tissue and block redundant…
08 Feb 22
Abbott's investigational dual-chamber pacemaker is designed to provide synchronous, beat-by-beat pacing of the right atrium and right ventricle…
27 Jan 22
The at-home solution will help improve innovation across the care continuum and decentralised clinical trials